Solid session for Novavax generates 0.65% gain Wednesday

Published: November 25 2022, 12:50 GMT+0

Solid session for Novavax generates 0.65% gain Wednesday

Investors are currently sidelined due to the Thanksgiving holiday but will return to their desks today. Looking back over the previous session Wednesday: generally flat but with a slight bullish bias, Novavax, Inc. ranged between $16.63 and $17.68 before closing higher at $17.03.

  • Wednesday's trading volume was 3.71 million shares which is slightly below the 21-day average of 4.43 million.

The US stock market is set to reconvene later today following Thanksgiving in a hour time. Nasdaq went up to 11,300 for a 0.99% change. Novavax climbed to $16.92 with similar gains seen throughout the Healthcare sector (up 0.732%).

The US vaccine developer is now trading 92.24% below the significant high of $217.97 it set around 11 months ago. So far in 2022, it has been doing worse than the Nasdaq by 47.45%. Novavax is currently trading with a market cap of $1.34 billion with an average daily volume of 4.43 million shares. Novavax expected revenue of $586.25 million with an EPS of $2.21.

A look at other health care stocks also showed bullish price action as Novo Nordisk gained 2.12%, as it traded at $117.83. Medtronic added 1.4% to its value, and traded at $79. Abbott Laboratories traded at $106 after closing Wednesday's trading day at $104.87 (up 1.1%).